Tuttle Capital Management Launches 2x Inverse Regional Bank

Tuttle Capital Management Launches 2x Inverse Regional Bank

GREENWICH, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE) -- via IBN -- The 2x Inverse Regional Bank ETF, (NASDAQ: SKRE), will start trading...
Hub Group, Inc. 2-for-1 Stock Split

Hub Group, Inc. 2-for-1 Stock Split

OAK BROOK, Ill., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Hub Group, Inc. (NASDAQ: HUBG) today announced a 2-for-1 stock split of its...
Homology Medicines Receives NASDAQ Notification Regarding

Homology Medicines Receives NASDAQ Notification Regarding

Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement BEDFORD, Mass.,...
Eterna Therapeutics Grants New President and CEO Sanjeev

Eterna Therapeutics Grants New President and CEO Sanjeev

CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed...
Global Systems Dynamics, Inc.’s Provides Update on Nasdaq

Global Systems Dynamics, Inc.’s Provides Update on Nasdaq

HOUSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Global System Dynamics, Inc. (Nasdaq: GSD, GSDWW, GSDWU) (“GSD” or the “Company”) today provided an...
XBP Europe to Ring Nasdaq Opening Bell on January 5, 2024

XBP Europe to Ring Nasdaq Opening Bell on January 5, 2024

LONDON and NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- XBP Europe (“XBP” or the “Company”) (NASDAQ: XBP and XBPEW), today announced...
SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split

SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split

SIOUX FALLS, S.D., Jan. 02, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform...
ARHT Media Inc. Issues Shares Related to Semi-Annual

ARHT Media Inc. Issues Shares Related to Semi-Annual

TORONTO, Jan. 02, 2024 (GLOBE NEWSWIRE) -- ARHT Media Inc. ("ARHT" or "the Company") (TSXV: ART), (OTCQB: ARHTF) the global leader in...
Bluejay Diagnostics Announces Closing of .5 Million

Bluejay Diagnostics Announces Closing of $3.5 Million

ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing...
Oncternal Therapeutics Reports Inducement Award Under

Oncternal Therapeutics Reports Inducement Award Under

SAN DIEGO, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of...
Stelmine closes 0,300 private placement

Stelmine closes $700,300 private placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. QUEBEC, Dec. 30, 2023 (GLOBE...
Vanguard Announces Final Cash Distributions for the

Vanguard Announces Final Cash Distributions for the

TORONTO, Dec. 28, 2023 (GLOBE NEWSWIRE) --  Vanguard Investments Canada Inc. today announced the final December 2023 cash distributions for certain Vanguard...